Inactive Instrument

Highlights IRRAS AB (publ) London S.E.

Equities

0GDW

SE0008321202

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Sweden's Irras Files for Delisting as Privatization Nears Completion	23-10-20	MT
Legacy Capital Partners S.C.A. I, Spetses Investments Ltd, Bacara Holdings Limited, Lexington Holding Assets Ltd and Panormos Holding Limited completed the acquisition of a 26.6% stake in IRRAS AB (OM : IRRAS).	23-09-03	CI
IR Holding Bidco Extends Acceptance Period for Irras Takeover	23-08-22	MT
IRRAS AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-04	CI
Irras' Independent Bid Panel Backs IR Holding's SEK143 Million Takeover Offer	23-07-24	MT
Irras Surges 19% on Takeover Offer From IR Holding Bidco	23-06-30	MT
Legacy Capital Partners S.C.A. I, Spetses Investments Ltd, Bacara Holdings Limited, Lexington Holding Assets Ltd and Panormos Holding Limited agreed to acquire IRRAS AB (OM : IRRAS) for approximately SEK 140 million.	23-06-29	CI
IRRAS AB Provides Sales Guidance for the Second Quarter of 2024	23-06-29	CI
IRRAS AB Shifts Commercial Strategy to Focus Resources on United States Market Opportunity	23-06-29	CI
IRRAS AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-17	CI
IRRAS AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-02-16	CI
IRRAS AB Announces That the Publication of the First Comparative Study	23-02-13	CI
IRRAS Receives US FDA 510(K) Clearance for Its Next Generation IRRAflow Control Unit	22-12-12	CI
IRRAS Announces Commercial Partnership with Medtronic in the United States for Its Irraflow System	22-11-14	CI
IRRAS AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI
IRRAS AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-07-22	CI
IRRAS AB Provides Revenue Guidance for the Year 2022	22-07-04	CI
IRRAS AB Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-27	CI
IRRAS Announces Regulatory Approval of IRRAflow in Australia	22-03-11	CI
IRRAS AB Announces First Global Patient Treatment with Next-Generation IRRAflow® System	22-03-03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights IRRAS AB (publ) London S.E.

Equities

0GDW

SE0008321202

Highlights

Filters